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Baculovirus expression is a time-tested technique to produce proteins in insect cells, in high 
quality and quantity for a range of applications. MultiBac is a baculovirus expression system 
we developed originally for producing multiprotein complexes comprising many subunits, for 
structural and mechanistic studies. First introduced in 2004, MultiBac is now in use in many 
laboratories world-wide, accelerating research programmes in academia and industry. We have 
continuously optimized our MultiBac system, providing customized reagents and standard 
operating protocols to facilitate its use also by non-specialists. More recently, we have 
generated MultiBac genomes tailored for specific purposes, for example to produce humanized 
glycoproteins, high-value pharmaceutical targets including kinases, viral polymerases, and 
virus-like particles (VLPs) as promising vaccine candidates. By altering the host tropism of the 
baculovirion, we created MultiBacMam, a heterologous DNA delivery toolkit to target 
mammalian cells, tissues and organisms. Introducing CRISPR/Cas modalities, we set the stage 
for large-scale genomic engineering applications utilizing this high capacity DNA delivery 
nanodevice. Exploiting synthetic biology approaches and bottom-up design, we engage in 
optimizing the properties of our baculoviral genome, also to improve manufacturing at scale. 




• MultiBac system unlocks structure and mechanism of multiprotein complexes. 
• Non-integrative DNA delivery system with unprecedented cargo capacity. 
• Host cell tropism can be engineered to target mammalian cells, tissues, and organisms. 




MultiBac Origins: The Nuts and Bolts 
Our interest in the baculovirus expression system dates from our work at the Swiss Federal 
Institute of Technology, ETH Zürich, in the laboratory of Tim Richmond, an expert in 
chromatin biology. It was the late 1990s and Tim had just determined the high-resolution 
structure of the nucleosome core particle, a seminal contribution to structural biology and a 
definite milestone in our understanding of chromatin architecture [1]. Nucleosomes comprise 
eight histone proteins organised in the so-called histone octamer, around which wraps a DNA 
superhelix. The Richmond team had produced all components recombinantly. Nucleosomes 
are the central building units of chromatin, and a host of protein factors engage with this key 
component of the hereditary material. Many of these factors are multiprotein complexes, often 
comprising 10 or more subunits. The low abundance of these vital protein specimens, 
exacerbated by compositional heterogeneity, typically impeded their extraction from native 
source material in the quality and quantity required for detailed mechanistic studies. In the case 
of the nucleosome, recombinant production of the components had fostered the breakthrough 
enabling near atomic structure determination. Consequently, we endeavoured to produce our 
protein complexes of interest similarly, using recombinant overproduction techniques.  
This, however, was easier said than done. Back then, the recombinant toolbox to produce 
complexes, was fairly rudimentary, to say the least. Existing technology was mostly confined 
to produce small, binary complexes in E. coli, the common prokaryotic host. Of note, the 
components of the nucleosome had been produced as inclusion bodies, and then reconstituted 
by refolding, an approach wholesale unfeasible for the much larger eukaryotic subunits, many 
of them with multidomain architecture, in our complexes of interest totalling up to and beyond 
a megadalton in combined molecular weight. We spent a rather depressing aggregate of post-
doc years in trying most of not all recombinant expression systems then available, including 
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Pichia pastoris, a yeast which was the hot ‘kid-in-the-block’ for eukaryotic protein production 
in those days. Unfortunately, all our efforts to produce the complexes we wished to investigate 
failed, soundly and comprehensively.  
Things took a turn to the better, however. Tim had met Jane Endicott, an expert kinase 
structural biologist then at Oxford University. Jane used baculovirus expression prolifically to 
produce the kinases they crystallized, and she kindly offered to help out by training one of us 
in her laboratory. Very soon, the lead author of the present article spent two wonderful weeks 
in Oxford with the Endicott team, learning the basics of the trade. Incidentally, a leading expert 
in baculovirus technology worked at that time in the nearby virology institute, Polly Roy. Jane 
organized a meeting, and Polly in her very compelling way instructed us in what, in her view, 
was the solution to all our problems: “You must place all recombinant genes on one single 
baculovirus and then you have your complex.” Back in Zürich, thoroughly inspired and 
motivated, we rolled up our sleeves to develop the reagents and protocols that culminated in 
the MultiBac system (Figure 1) [2-11].     
Our initial efforts focused on devising a way to simplify and standardize combination of the 
many genes encoding for the complex subunits into multigene expression constructs and then 
to introduce these in a straight forward manner into the baculoviral genome. We started from 
a baculoviral genome available from Invitrogen, which exists in from of a bacterial artificial 
chromosome (BAC). We provided a set of small transfer plasmids comprising multiplication 
modules and site-specific recombination elements to assemble multigene expression cassettes 
[2, 4, 5]. To facilitate DNA assembly, we utilized sequence and ligation independent protocols 
in combination with plasmid fusion in a process we termed tandem recombineering (TR) [12], 
which we subsequently implemented in high throughput in a robotics set-up [8, 13, 14]. In 
addition to a Tn7 attachment site for transposon mediated heterologous DNA insertion, we also 
engineered a DNA sequence encoding a loxP site into the viral backbone, to allow integration 
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by Cre recombinase-mediated plasmid fusion of additional functionalities (e.g. phosphatases, 
kinases, glycosylases, deglycosylases, chaperones etc.) to modify, activate or inactivate a 
particular protein specimen produced from the Tn7 site on the same baculoviral genome [6, 
15]. This additional site proved to be highly useful for generating customized MultiBac 
baculoviral genomes for specific applications (Figure 1) [10, 16-22].  All along, our ambition 
was to streamline the handling of the entire system, including composite baculovirus 
generation, tissue culture, virus amplification and protein complex production, to render the 
technique accessible to a wide range of users including non-specialists who would only 
occasionally use this tool. The insertion of a yellow fluorescent protein as a marker proved 
particularly useful – by monitoring the fluorescent signal, or simply by looking at the colour 
of the culture turning greenish, we could determine when cultures needed to be harvested to 
obtain best results [4].    
Immediately, the MultiBac system was well received in the community and the interest 
appears to continue unabated since. Tantalizing structures have been determined, revealing 
exciting mechanisms (selection shown in Figure 1), incidentally including structures of 
chromatin interacting protein complexes bound to nucleosomes of the kind for which the 
system was originally envisaged [23-26].  It is probably fair to say, and foremostly gratifying, 
that MultiBac has become a system of choice for producing eukaryotic multiprotein complexes 
for structural and functional studies at high resolution by X-ray crystallography and electron 
cryo-microscopy. 
Together with Dan Fitzgerald, a fellow post-doc in Zürich, we installed a small facility in 
the basement of ETH’s molecular biology building, to operate MultiBac as a platform 
physically separate from all yeast and E.coli expressions in the department, with the aim to 
forestall contamination which had plagued our work in the initial stages when we had been less 
rigorous in our handling. This first ‘MultiBac facility’ was an improvised enterprise – we had 
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decided not to use incubators, but to temperature the entire room to 27°C, using a makeshift 
set-up of modified shakers, fans and thermostats bought from the supermarket which we 
combined with a feed-back loop to keep the temperature within the narrow range tolerated by 
the insect cells we cultured. It soon became our favourite locality in the building, remote and 
cosy to work in. However, in spite of great efforts to impose and maintain good and sterile 
laboratory practice, we noticed bouts of contamination in the facility, recurring exactly every 
third week-end in a month. It caused some headache to track down the source of this calamity. 
It turned out to be yeast, and moreover to coincide precisely with the departmental Happy Hour 
scheduled exactly at the same intervals, where quite naturally significant quantities of beer 
were consumed. We reacted by ruling that use of the MultiBac facility and participating in 
Happy Hour were mutually exclusive, and our contamination issue was swiftly resolved.  
Broadening the scope: MultiBac moves to EMBL  
Soon the MultiBac platform migrated together with the Berger team to the European 
Molecular Biology Laboratory, EMBL Grenoble. Together with facility manager Fred 
Garzoni, we set up a much larger facility serving the sizeable structural biology community in 
Grenoble and beyond [27]. We participated in transnational access programmes bringing many 
scientists from diverse backgrounds to our laboratory to learn the technique, based on their own 
projects. This was an intensive and horizon broadening experience for us. We were exposed to 
a wide range of projects and realized that the baculovirus system, and specifically MultiBac, 
had a significantly broader scope beyond structural biology [3]. Applications which stood out 
were the use of our system to produce influenza polymerase, a long elusive protein complex 
controlling replication and transcription of this pathogen [28]. In a nature-inspired approach, 
we utilized a single ORF encoding all subunits of the polymerase within a polyprotein, cleaved 
apart co-translationally by a highly specific protease likewise encoded in the ORF, to unlock 
this high-value drug target to high-resolution structure analysis [29, 30]. A further highlight 
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was MultiBac-produced recombinant adeno-associated virus (AAV) for gene therapy of 
obesity in a rodent model [3, 31]. This triggered our keen interest, prompting us to invest in 
developing the system towards new and exciting applications [9, 17].    
Synthetic Biology: The MultiBac platform in Bristol 
Our MultiBac platform in its current embodiment is operating at the University of Bristol, 
UK, underpinning research and development in the Bristol Synthetic Biology Centre, 
BrisSynBio, and the new Max Planck Bristol Centre for Minimal Biology inaugurated in March 
2019. Game-changing developments in custom DNA synthesis and the concomitant 
remarkable reduction in costs set the stage for revisiting all aspects of our technology for 
improvement. We are close to the point where cloning heterologous gene expression cassettes 
and their conjoining into multigene circuitry can be confidently outsourced to commercial 
suppliers, making redundant much of the DNA assembly routines in research laboratories. 
Moreover, the total synthesis of a baculoviral genome in a bottom-up approach is in principle 
now possible. The baculovirus we use in cell culture exists in a narrowly defined, confined 
habitat rendering a significant portion of the genomic content probably superfluous. For 
instance, genes regulating virus per os uptake, and modalities providing long-term protection 
against exposure can conceivably be disposed of. By data mining and comparative genomics, 
we provided a blueprint for a minimal, condensed baculoviral genome which we are 
assembling in a hybrid approach, iteratively grafting synthetic DNA segments we rewired on 
the MultiBac genome replacing wild-type sequence [9, 32].  Our objective here is to alleviate 
detrimental features of the baculovirus, notably its genomic instability during serial passage 
for amplification which poses an impediment for manufacturing at pharmaceutically scale. At 
the same time, eliminating instability hotspots and superfluous genetic information from the 
baculoviral genome will further increase its already remarkable heterologous DNA cargo 
capacity (in our hands 100 kb). This unprecedented DNA cargo capacity is particularly 
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interesting when combined with reconfiguring the host tropism of baculovirus which in nature 
is narrowly confined for specific insect cells. It was shown that by pseudotyping for example 
with vesicular stomatitis virus glycoprotein, baculovirus can be reconfigured into a DNA 
delivery tool for mammalian cells and tissues [33, 34].  We seized this opportunity and created 
MultiBacMam, a MultiBac baculovirus-based transient or integrative delivery system with 
unprecedented cargo capacity for heterologous DNA circuitry (Figure 1) [17, 19].  
Gene therapy today is dominated by lentivirus, adenovirus and adeno-associated virus, each 
with their own merits and shortcomings. In our view, baculovirus has the potential to become 
a highly attractive replacement technology for current viral vectors, based on its far superior 
DNA cargo capacity, the ease of engineering, and much simpler manufacturing, particularly 
once the genomic instability issues are resolved. Moreover, baculovirus is non-integrative, does 
not scar the host genome and, importantly, does not replicate in a mammalian host. We 
anticipate rapid progress and exciting breakthroughs in the near future, in baculovirus 
development towards a high capacity delivery system for therapeutic genome engineering, 
potentiated by powerful DNA insertion methodologies including CRISPR/Cas. The race is on 
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Figure and Legend 
 
Figure 1. MultiBac Applications. The MultiBac system is depicted schematically in the 
centre.  It consists of an engineered baculoviral genome which exists as a bacterial artificial 
chromosome (BAC) in specialized bacterial cells. Foreign DNA can be introduced into this 
BAC using a set of helper plasmids comprising the multigene circuitry of choice, by a variety 
of means including Tn7 mediated transposition and/or site directed imsertion by Cre 
recombinase [2-5, 8, 10, 11]. Originally, we designed the MultiBac system for expressing 
heterologous multiprotein complexes in insect cells. A selection of recent high-impact 
structures of samples produced using MultiBac is shown on the left, marked by their Protein 
Data Bank identifier (PDB-ID). 6GEJ, SWR1-nucleosome complex [25]; 6F3T, human TFIID 
subcomplex TAF5-TAF6-TAF9 [35]; 6HLP, human neurokinin 1 receptor GPCR [36]; 6R8F, 
human BRISC-SHMT2 complex [37]; 6QJ4, Ycs4-Brn1/Smc4hd–Brn1C complex [38]; 
6HCR, ADDomer virus-like particle (VLP). MultiBac is successfully used for a range of 
applications beyond producing protein complexes for structural and mechanistic studies. For 
example, customized MultiBac baculoviral genomes were prepared to express virus-like 
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particles (VLPs), which are promising vaccine candidates as they resemble live viruses but do 
not contain genetic material and are thus safe [22, 39]. Here, an influenza VLP is shown in a 
schematic drawing and in an electron micrograph [22] (centre, top). A different example is 
MultiBacTAG, a customized MultiBac baculovirus capable of genetic code expansion [18] 
(centre, bottom). MultiBacTag exploits an orthogonal tRNA/tRNA synthetase pair to insert 
artificial amino acids (ncAA) into polypeptide chains at defined sites by means of AMBER 
codon (UAG) suppression [18, 40]. By altering the tropism of the baculovirion, MultiBac can 
be turned into a powerful high-capacity DNA delivery device into mammalian cells, tissues 
and even organisms (right), to faithfully deliver multicomponent DNA circuitry transiently or 
stably by genomic insertion using CRISPR/Cas technology [9, 17, 19, 41]. For a more detailed 
conspectus of MultiBac applications see recent review articles by our group [9, 10, 17]. 
 
